Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

14-3-3eta shows potential as a drug target for the treatment of arthritis

June 26, 2015

Guselkumab and ustekinumab do not meet primary endpoint in rheumatoid arthritis trial

June 25, 2015

Safety of tesevatinib assessed in a phase Ib trial

June 25, 2015

Encouraging first-in-human data obtained with BI-836826 in CLL

June 25, 2015

New AAV-based gene therapy presented for the treatment of brain arteriovenous malformation

June 23, 2015

Results for CR-6086 in preclinical models of rheumatoid arthritis

June 23, 2015

Final data confirm benefit of imeglimin in phase IIb diabetes trial

June 23, 2015

First-in-human results reported for MLN-1117 in patients with solid tumors

June 23, 2015

Celon presents data on new PI3Kdelta inhibitor

June 23, 2015

Mutations identified in three retinal dystrophy genes related o retinitis pigmentosa

June 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...